Biomedical Engineering Reference
In-Depth Information
31. Segers, V.F.M., Lee, R.T.: Protein therapeutics for cardiac regeneration after myocardial
infarction. J. Cardiovasc. Transl. Res. 3(5), 469-477 (2010)
32. White, H.D., Chew, D.P.: Acute myocardial infarction. Lancet 372(9638), 570-584 (2008)
33. Syed, I.S., Sanborn, T.A., Rosengart, T.K.: Therapeutic angiogenesis: a biologic bypass.
Cardiology 101(1-3), 131-143 (2004)
34. Pearlman, J.D., et al.: Magnetic resonance mapping demonstrates benefits of VEGF-induced
myocardial angiogenesis. Nat. Med. 1(10), 1085-1089 (1995)
35. Harada, K., et al.: Vascular endothelial growth factor administration in chronic myocardial
ischemia. Am. J. Physiol. 270(5 Pt 2), H1791-H1802 (1996)
36. Lopez, J.J., et al.: VEGF administration in chronic myocardial ischemia in pigs. Cardiovasc.
Res. 40(2), 272-281 (1998)
37. Banai, S., et al.: Angiogenic-induced enhancement of collateral blood flow to ischemic
myocardium by vascular endothelial growth factor in dogs. Circulation 89(5), 2183-2189
(1994)
38. Henry, T.D., et al.: Intracoronary administration of recombinant human vascular endothelial
growth factor to patients with coronary artery disease. Am. Heart J. 142(5), 872-880 (2001)
39. Losordo, D.W., et al.: Gene therapy for myocardial angiogenesis: initial clinical results with
direct
myocardial
injection
of
phVEGF165
as
sole
therapy
for
myocardial
ischemia.
Circulation 98(25), 2800-2804 (1998)
40. Symes, J.F., et al.: Gene therapy with vascular endothelial growth factor for inoperable
coronary artery disease. Ann. Thorac. Surg. 68(3), 830-836 (1999)
41. Vale, P.R., et al.: Left ventricular electromechanical mapping to assess efficacy of
phVEGF(165) gene transfer for therapeutic angiogenesis in chronic myocardial ischemia.
Circulation 102(9), 965-974 (2000)
42. Rosengart, T.K., et al.: Angiogenesis gene therapy: phase I assessment of direct
intramyocardial administration of an adenovirus vector expressing VEGF121 cDNA to
individuals with clinically significant severe coronary artery disease. Circulation 100(5),
468-474 (1999)
43. Henry, T.D., et al.: The VIVA trial: vascular endothelial growth factor in ischemia for
vascular angiogenesis. Circulation 107(10), 1359-1365 (2003)
44. Kastrup, J., et al.: Direct intramyocardial plasmid vascular endothelial growth factor-A165
gene therapy in patients with stable severe angina pectoris: a randomized double-blind
placebo-controlled study: the Euroinject one trial. J. Am. Coll. Cardiol. 45(7), 982-988
(2005)
45. Hedman, M., et al.: Safety and feasibility of catheter-based local intracoronary vascular
endothelial growth factor gene transfer in the prevention of postangioplasty and in-stent
restenosis and in the treatment of chronic myocardial ischemia: phase II results of the kuopio
angiogenesis trial (KAT). Circulation 107(21), 2677-2683 (2003)
46. Yanagisawa-Miwa, A., et al.: Salvage of infarcted myocardium by angiogenic action of basic
fibroblast growth factor. Science 257(5075), 1401-1403 (1992)
47. Grines, C.L., et al.: Angiogenic gene therapy (AGENT) trial in patients with stable angina
pectoris. Circulation 105(11), 1291-1297 (2002)
48. Grines, C.L., et al.: A randomized, double-blind, placebo-controlled trial of Ad5FGF-4 gene
therapy and its effect on myocardial perfusion in patients with stable angina. J. Am. Coll.
Cardiol. 42(8), 1339-1347 (2003)
49. Henry, T.D., et al.: Effects of Ad5FGF-4 in patients with angina: An analysis of pooled data
from the AGENT-3 and AGENT-4 trials. J. Am. Coll. Cardiol. 50(11), 1036-1046 (2007)
50. Zachary, I., Morgan, R.D.: Therapeutic angiogenesis for cardiovascular disease: biological
context, challenges, prospects. Heart 97(3), 181-189 (2011)
51. Annex, B.H., Simons, M.: Growth factor-induced therapeutic angiogenesis in the heart:
protein therapy. Cardiovasc. Res. 65(3), 649-655 (2005)
52. Rosinberg, A., et al.: Therapeutic angiogenesis for myocardial ischemia. Expert Rev.
Cardiovasc. Ther. 2(2), 271-283 (2004)
Search WWH ::
Custom Search